JPA Health acquires BioCentric, Inc. to expand capabilities in medical communications.
JPA Health expands capabilities through the acquisition of BioCentric, Inc., a medical communications agency. The deal combines BioCentric's medical affairs and commercial expertise with JPA Health's integrated services, predictive analytics, and AI-driven solutions. BioCentric specializes in pipeline product candidates, clinical trial acceleration, and HCP engagement. The acquisition aims to enhance engagements, capture meaningful insights, and drive positive behavior change.
May 24, 2024
3 Articles